Market News & Trends
Global Market for MicroRNA Research Tools to Reach $1 Billion by 2019
The last decade witnessed significant advancement in microRNA (miRNA) research leading to identification of novel miRNA genes, validation of miRNA targets and delineation of the…
Peter Bigelow Elected as PBOA's First-Ever Chairman
The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has…
Mystic Pharmaceuticals Introduces ArrowFish Nasal Vaccine and Drug Delivery System
Mystic Pharmaceuticals, Inc. today announced the availability of its Arrowfish™ nasal drug and biologic delivery system. This new generation delivery system utilizes Mystic’s patented VersiDoser®…
Global Non-Hodgkin Lymphoma Therapeutics Market Value to Hit $9.2 Billion
The global Non-Hodgkin Lymphoma (NHL) treatment market will increase in value from $5.6 billion in 2013 to $9.2 billion by 2020, representing a Compound Annual…
Morrison & Foerster's BioMeter Index Shows Reemergence of Late-Stage Deals
Morrison & Foerster returns with its Q3 edition of BioMeter, which reveals a big jump in the number of deals and average payments for Phase…
Cancer Research Technology Introduces Ximbio
Cancer Research Technology (CRT), the development and commercialization arm of Cancer Research UK, recently announced the launch of Ximbio (www.ximb.io), an online reagents portal for…
TesoRx & Aspen Group Conclude Investment & Licensing Agreement
TesoRx Pharma, LLC (http://www.tesorx.com), a specialty pharmaceutical company, recently announced it has licensed select international rights to TSX-002, the first unmodified oral-Testosterone replacement therapy, to…
EMD Millipore Introduces Single-Use Process Container Film for High-Volume Biopharmaceutical Applications
EMD Millipore, the life science division of Merck KGaA of Darmstadt, Germany, has expanded its single-use film offerings with the introduction of PureFlex Plus film,…
West's Vial2Bag DC Device Receives US FDA 510(k) Clearance & CE Mark
West Pharmaceutical Services, Inc. (NYSE: WST) recently announced it has received 510(k) clearance of the Vial2Bag DC device from the US FDA, and also the…
Ashland to Address Global Drug Development & Bioavailability Enhancement Trends
This past September, Ashland Specialty Ingredients, a commercial unit of Ashland Inc. (NYSE:ASH), opened a state-of-the-art pharmaceutical center of excellence in Wilmington, DE. The new…
Presage Biosciences Granted 5th US Patent for Arrayed Microinjection Platform
Presage Biosciences, an oncology company developing a radical new testing approach that incorporates human efficacy data much earlier in drug development and clinical trials, recently…
Pharmaceutical Industry Feeling Force of Tax Inversion Legislation, says GlobalData Analyst
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the…
Horizon Discovery Group Launches Collection of Highly Characterized Patient-Derived Xenograft Models of Breast Cancer
Horizon Discovery Group plc (Horizon), a leading provider of products, services and technologies in the field of genome engineering, today announced the launch of its…
Aduro Expands Collaboration With J&J Innovation & Janssen
Aduro BioTech, Inc. recently announced that it has entered into its second agreement with Janssen Biotech, Inc., part of the Janssen Pharmaceutical Companies of Johnson…
Zynerba Pharmaceuticals Raises $13 Million to Develop First & Only Transdermal Cannabinoid Therapies
Zynerba Pharmaceuticals, Inc. recently announced the successful closing of $13- million in funding. New investors in Zynerba include one of the top-seven life sciences public…
Raze Therapeutics Launches With $24-Million to Advance New Class of Oncology Therapeutics
Raze Therapeutics recently announced the closing of a $24-million Series A financing. Proceeds from the financing will be used to advance the development of a…
Auspherix & Domainex Announce Major Development Collaboration
Domainex Ltd. and Auspherix Pty Ltd recently announced a collaboration that will progress Auspherix’s novel anti-infective drug discovery program toward the nomination of a…
Horizon Discovery Group Signs Agreement With Top 10 Pharma Company
Horizon Discovery Group plc recently announced that its Horizon CombinatoRx division has been contracted by a top 10 pharma company to profile a lead oncology…
Endo Acquires Company for $2.6 Billion
Endo International plc and Auxilium Pharmaceuticals, Inc. recently announced they have entered into a definitive agreement under which Endo will acquire all of the outstanding…
